{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:58:58Z","timestamp":1792205938624,"version":"4.4.0"},"reference-count":114,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Cardiac pacing represents a key element in the field of electrophysiology and the treatment of conduction diseases. Since the first issue published in 1999, EP Europace has significantly contributed to the development and dissemination of the research in this area.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In the last 25 years, there has been a continuous improvement of technologies and a great expansion of clinical indications making the field of cardiac pacing a fertile ground for research still today. Pacemaker technology has rapidly evolved, from the first external devices with limited longevity, passing through conventional transvenous pacemakers to leadless devices. Constant innovations in pacemaker size, longevity, pacing mode, algorithms, and remote monitoring highlight that the fascinating and exciting journey of cardiac pacing is not over yet.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The aim of the present review is to provide the current \u2018state of the art\u2019 on cardiac pacing highlighting the most important contributions from the Journal in the field.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euad202","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T12:47:34Z","timestamp":1688820454000},"source":"Crossref","is-referenced-by-count":57,"title":["Cardiac pacing and lead devices management: 25 years of research at EP Europace journal"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7183-4278","authenticated-orcid":false,"given":"Pascal","family":"Defaye","sequence":"first","affiliation":[{"name":"Cardiology Department, University Hospital and Grenoble Alpes University , CS 10217, Grenoble Cedex 9, Grenoble 38043 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4590-8584","authenticated-orcid":false,"given":"Mauro","family":"Biffi","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4978-7177","authenticated-orcid":false,"given":"Mikhael","family":"El-Chami","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1280-7042","authenticated-orcid":false,"given":"Serge","family":"Boveda","sequence":"additional","affiliation":[{"name":"Clinique Pasteur, Heart Rhythm Department , Toulouse , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-0395","authenticated-orcid":false,"given":"Michael","family":"Glikson","sequence":"additional","affiliation":[{"name":"Cardiology Department, Jesselson Integrated Heart Center Shaare Zedek Medical Center and Hebrew University Faculty of Medicine , Jerusalem , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-2404","authenticated-orcid":false,"given":"Jonathan","family":"Piccini","sequence":"additional","affiliation":[{"name":"Duke University, Duke Clinical Research Institute , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5196-6249","authenticated-orcid":false,"given":"Marco","family":"Vitolo","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico Di Modena , Modena , Italy"},{"name":"Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia , Modena , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"key":"2023083020435751500_euad202-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/eupc.1998.0020","article-title":"Introducing Europace","volume":"1","author":"Sutton","year":"1999","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2013.08.093","article-title":"A short history on pacemakers","volume":"169","author":"Ward","year":"2013","journal-title":"Int J Cardiol"},{"key":"2023083020435751500_euad202-B3","first-page":"17","article-title":"A brief history of cardiac pacing","volume":"8","author":"Aquilina","year":"2006","journal-title":"Images Paediatr Cardiol"},{"key":"2023083020435751500_euad202-B4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/0310057X19860986","article-title":"The early history of cardiac pacing","volume":"47","author":"Ball","year":"2019","journal-title":"Anaesth Intensive Care"},{"key":"2023083020435751500_euad202-B5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archinte.1932.00150150115012","article-title":"Resuscitation of the stopped heart by intracardial therapy: ii. Experimental use of an artificial pacemaker","volume":"50","author":"Hyman","year":"1932","journal-title":"Arch Intern Med"},{"key":"2023083020435751500_euad202-B6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/europace\/euab232","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"24","author":"Glikson","year":"2022","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/europace\/eux381","article-title":"Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey","volume":"20","author":"Boveda","year":"2018","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B8","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad123","article-title":"2023 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on practical management of the remote device clinic","volume":"25","author":"Ferrick","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B9","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/europace\/euad043","article-title":"EHRA Clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS)","volume":"25","author":"Burri","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/europace\/euaa367","article-title":"EHRA Expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS)","volume":"23","author":"Burri","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/europace\/euab160","article-title":"Remote monitoring data from cardiac implantable electronic devices predicts all-cause mortality","volume":"24","author":"Ahmed","year":"2022","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11606-007-0392-0","article-title":"Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis","volume":"23","author":"Zhan","year":"2008","journal-title":"J Gen Intern Med"},{"key":"2023083020435751500_euad202-B13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2020.09.003","article-title":"Seventeen-year trend (2001\u20132017) in pacemaker and implantable cardioverter-defibrillator utilization based on hospital discharge database data: an analysis by age groups","volume":"84","author":"Zecchin","year":"2021","journal-title":"Eur J Intern Med"},{"key":"2023083020435751500_euad202-B14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ehjqcco\/qcz065","article-title":"European Society of Cardiology: Cardiovascular Disease Statistics 2019 (executive summary)","volume":"6","author":"Timmis","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2023083020435751500_euad202-B15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/europace\/euu233","article-title":"Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry","volume":"17","author":"Gadler","year":"2014","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/europace\/euab193","article-title":"European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working roup for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology","volume":"24","author":"Aktaa","year":"2022","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B17","volume-title":"An aging world: 2015","author":"He","year":"2016"},{"key":"2023083020435751500_euad202-B18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2459\/JCM.0000000000001220","article-title":"Clinical implications of assessing frailty in elderly patients treated with permanent cardiac pacing","volume":"23","author":"Boriani","year":"2022","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2023083020435751500_euad202-B19","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/europace\/euac123","article-title":"EHRA Expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)","volume":"25","author":"Savelieva","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ahj.2003.06.005","article-title":"Increasing rates of cardiac device infections among Medicare beneficiaries: 1990\u20131999","volume":"147","author":"Cabell","year":"2004","journal-title":"Am Heart J"},{"key":"2023083020435751500_euad202-B21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European Society of Cardiology: cardiovascular disease statistics 2021","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur Heart J"},{"key":"2023083020435751500_euad202-B22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/17434440.2021.1866543","article-title":"Pacing devices to treat bradycardia: current status and future perspectives","volume":"18","author":"Biffi","year":"2021","journal-title":"Expert Rev Med Devices"},{"key":"2023083020435751500_euad202-B23","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad065","article-title":"Avoiding unnecessary ventricular pacing is associated with reduced incidence of heart failure hospitalizations and persistent atrial fibrillation in pacemaker patients","volume":"25","author":"Arnold","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/europace\/euy286","article-title":"Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial","volume":"21","author":"Boriani","year":"2019","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.hrthm.2022.09.019","article-title":"Pacing-induced cardiomyopathy: a systematic review and meta-analysis of definition, prevalence, risk factors, and management","volume":"20","author":"Somma","year":"2023","journal-title":"Heart Rhythm"},{"key":"2023083020435751500_euad202-B26","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/europace\/euad025","article-title":"Clinical impact of right ventricular pacing burden in patients with post-transcatheter aortic valve replacement permanent pacemaker implantation","volume":"25","author":"Tsushima","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/europace\/euy263","article-title":"Reducing right ventricular pacing burden: algorithms, benefits, and risks","volume":"21","author":"Jankelson","year":"2019","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B28","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1056\/NEJMoa013040","article-title":"Ventricular pacing or dual-chamber pacing for sinus-node dysfunction","volume":"346","author":"Lamas","year":"2002","journal-title":"N Engl J Med"},{"key":"2023083020435751500_euad202-B29","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.288.24.3115","article-title":"Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) trial","volume":"288","author":"Wilkoff","year":"2002","journal-title":"JAMA"},{"key":"2023083020435751500_euad202-B30","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJMoa071880","article-title":"Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease","volume":"357","author":"Sweeney","year":"2007","journal-title":"N Engl J Med"},{"key":"2023083020435751500_euad202-B31","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/eurheartj\/ehr022","article-title":"A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome","volume":"32","author":"Nielsen","year":"2011","journal-title":"Eur Heart J"},{"key":"2023083020435751500_euad202-B32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/eurheartj\/ehu336","article-title":"Long-term clinical effects of ventricular pacing reduction with a changeover mode to minimize ventricular pacing in a general pacemaker population","volume":"36","author":"Stockburger","year":"2015","journal-title":"Eur Heart J"},{"key":"2023083020435751500_euad202-B33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/eurjhf\/hfp074","article-title":"Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial","volume":"11","author":"Gervais","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2023083020435751500_euad202-B34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/europace\/euz321","article-title":"A randomized controlled trial of cardiac resynchronization therapy in patients with prolonged atrioventricular interval: the REAL-CRT pilot study","volume":"22","author":"Botto","year":"2020","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jacep.2016.11.011","article-title":"Atrioventricular interval extension is highly efficient in preventing unnecessary right ventricular pacing in sinus node disease: a randomized cross-over study versus dual- to atrial single-chamber mode switch","volume":"3","author":"Calvi","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2023083020435751500_euad202-B36","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/europace\/euw440","article-title":"Presyncopal episodes after implantation of dual-chamber pacemaker programmed in SafeR pacing mode","volume":"19","author":"Antonio","year":"2017","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/europace\/eur365","article-title":"Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing","volume":"14","author":"Nielsen","year":"2012","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B38","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/europace\/euw364","article-title":"Single lead atrial vs. dual chamber pacing in sick sinus syndrome: extended register-based follow-up in the DANPACE trial","volume":"19","author":"Brandt","year":"2017","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B39","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/europace\/eux207","article-title":"Atrioventricular dromotropathy: evidence for a distinctive entity in heart failure with prolonged PR interval?","volume":"20","author":"Salden","year":"2018","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B40","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/europace\/euy058","article-title":"Permanent His-bundle pacing: a systematic literature review and meta-analysis","volume":"20","author":"Zanon","year":"2018","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B41","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad082","article-title":"The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale","volume":"25","author":"Pastore","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B42","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","article-title":"Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark","volume":"35","author":"Kirkfeldt","year":"2014","journal-title":"Eur Heart J"},{"key":"2023083020435751500_euad202-B43","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/europace\/euz166","article-title":"Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement\/upgrade in a contemporary population: observations from the multicentre DECODE registry","volume":"21","author":"Biffi","year":"2019","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/europace\/euaa301","article-title":"Utilization and perception of same-day discharge in electrophysiological procedures and device implantations: an EHRA survey","volume":"23","author":"K\u00f6nig","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/europace\/euaa221","article-title":"Avoiding implant complications in cardiac implantable electronic devices: what works?","volume":"23","author":"Frausing","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B46","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.hrthm.2005.06.011","article-title":"Incidence and predictors of cardiac perforation after permanent pacemaker placement","volume":"2","author":"Mahapatra","year":"2005","journal-title":"Heart Rhythm"},{"key":"2023083020435751500_euad202-B47","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/eurheartj\/ehab767","article-title":"Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up","volume":"43","author":"El-Chami","year":"2022","journal-title":"Eur Heart J"},{"key":"2023083020435751500_euad202-B48","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/europace\/euac105","article-title":"Iatrogenic cardiac perforation due to pacemaker and defibrillator leads: a contemporary multicentre experience","volume":"24","author":"Waddingham","year":"2022","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B49","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/europace\/euz120","article-title":"The management of cardiac implantable electronic device lead perforations: a multicentre study","volume":"21","author":"Acha M","year":"2019","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/europace\/euac112","article-title":"Rate and nature of complications with leadless transcatheter pacemakers compared with transvenous pacemakers: results from an Italian multicentre large population analysis","volume":"25","author":"Palmisano","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B51","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.hrthm.2011.12.014","article-title":"Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study","volume":"9","author":"Udo","year":"2012","journal-title":"Heart Rhythm"},{"key":"2023083020435751500_euad202-B52","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jacc.2015.12.067","article-title":"Implantable cardiac defibrillator lead failure and management","volume":"67","author":"Swerdlow","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2023083020435751500_euad202-B53","doi-asserted-by":"crossref","first-page":"iv3","DOI":"10.1093\/europace\/euab042","article-title":"Epidemiology of cardiac implantable electronic device infections: incidence and risk factors","volume":"23","author":"Han","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B54","doi-asserted-by":"crossref","first-page":"iv11","DOI":"10.1093\/europace\/euab071","article-title":"Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxis","volume":"23","author":"Blomstrom-Lundqvist","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B55","doi-asserted-by":"crossref","first-page":"iv33","DOI":"10.1093\/europace\/euab126","article-title":"Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRX\u2122 antibacterial envelope","volume":"23","author":"Boriani","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B56","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1901111","article-title":"Antibacterial envelope to prevent cardiac implantable device infection","volume":"380","author":"Tarakji","year":"2019","journal-title":"N Engl J Med"},{"key":"2023083020435751500_euad202-B57","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/europace\/euac119","article-title":"Efficacy of the antibacterial envelope to prevent cardiac implantable electronic device infection in a high-risk population","volume":"24","author":"Chaudhry","year":"2022","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B58","first-page":"1002","article-title":"Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial","volume":"19","author":"Masiero","year":"2017","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B59","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1511643","article-title":"A leadless intracardiac transcatheter pacing system","volume":"374","author":"Reynolds","year":"2016","journal-title":"N Engl J Med"},{"key":"2023083020435751500_euad202-B60","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.hrthm.2018.08.005","article-title":"Updated performance of the Micra transcatheter pacemaker in the real-world setting: a comparison to the investigational study and a transvenous historical control","volume":"15","author":"El-Chami","year":"2018","journal-title":"Heart Rhythm"},{"key":"2023083020435751500_euad202-B61","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamacardio.2021.2621","article-title":"Contemporaneous comparison of outcomes among patients implanted with a leadless vs transvenous single-chamber ventricular pacemaker","volume":"6","author":"Piccini","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2023083020435751500_euad202-B62","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/europace\/euad016","article-title":"Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups","volume":"25","author":"Boveda","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jacep.2021.11.002","article-title":"Primary results on safety and efficacy from the LEADLESS II-phase 2 worldwide clinical trial","volume":"8","author":"Reddy","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2023083020435751500_euad202-B64","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMoa2300080","article-title":"A dual-chamber leadless pacemaker","volume":"388","author":"Knops","year":"2023","journal-title":"N Engl J Med"},{"key":"2023083020435751500_euad202-B65","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/europace\/euab315","article-title":"Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker","volume":"24","author":"Piccini","year":"2022","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B66","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/europace\/euab156","article-title":"Leadless left ventricular endocardial pacing for CRT upgrades in previously failed and high-risk patients in comparison with coronary sinus CRT upgrades","volume":"23","author":"Sidhu","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B67","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/europace\/euaa342","article-title":"European Experience with a first totally leadless cardiac resynchronization therapy pacemaker system","volume":"23","author":"Carabelli","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B68","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/europace\/euac066","article-title":"Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA\/HRS\/LAHRS\/APHRS","volume":"24","author":"Boersma","year":"2022","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B69","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/eurheartj\/ehz316","article-title":"Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982\u20132018)","volume":"40","author":"Olsen","year":"2019","journal-title":"Eur Heart J"},{"key":"2023083020435751500_euad202-B70","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/europace\/euab028","article-title":"Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score","volume":"23","author":"Ahmed","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B71","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/eurheartj\/ehaa010","article-title":"European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"41","author":"Blomstr\u00f6m-Lundqvist","year":"2020","journal-title":"Eur Heart J"},{"key":"2023083020435751500_euad202-B72","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/europace\/euy050","article-title":"2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS\/HRS\/LAHRS","volume":"20","author":"Bongiorni","year":"2018","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B73","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/eurheartj\/ehx080","article-title":"The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes","volume":"38","author":"Bongiorni","year":"2017","journal-title":"Eur Heart J"},{"key":"2023083020435751500_euad202-B74","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/europace\/euaa103","article-title":"Results of the Patient-Related Outcomes of Mechanical lead Extraction Techniques (PROMET) study: a multicentre retrospective study on advanced mechanical lead extraction techniques","volume":"22","author":"Starck","year":"2020","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B75","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/europace\/euac200","article-title":"A head-to-head comparison of laser vs. powered mechanical sheaths as first choice and second line extraction tools","volume":"25","author":"Zsigmond","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B76","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/europace\/euab209","article-title":"Permanent pacemaker implantation following transcatheter aortic valve implantation using self-expandable, balloon-expandable, or mechanically expandable devices: a network meta-analysis","volume":"23","author":"Ravaux","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B77","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/pace.12150","article-title":"Complete atrioventricular block after TAVI: when is pacemaker implantation safe?","volume":"36","author":"Schwerg","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"2023083020435751500_euad202-B78","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/CIRCULATIONAHA.113.005479","article-title":"Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function","volume":"129","author":"Urena","year":"2014","journal-title":"Circulation"},{"key":"2023083020435751500_euad202-B79","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/europace\/euac042","article-title":"Remote ECG monitoring to reduce complications following transcatheter aortic valve implantations: the Redirect TAVI study","volume":"24","author":"Natarajan","year":"2022","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B80","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/europace\/euz261","article-title":"Need for pacemaker implantation in patients with normal QRS duration immediately after transcatheter aortic valve implantation","volume":"21","author":"Schoechlin","year":"2019","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B81","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/europace\/euw174","article-title":"Severe conduction defects requiring permanent pacemaker implantation in patients with a new-onset left bundle branch block after transcatheter aortic valve implantation","volume":"19","author":"Nijenhuis","year":"2017","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B82","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/europace\/euac027","article-title":"Management of conduction disorders after transcatheter aortic valve implantation: results of the EHRA survey","volume":"24","author":"Badertscher","year":"2022","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B83","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/europace\/euac008","article-title":"Long-term clinical impact of permanent pacemaker implantation in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis","volume":"24","author":"Zito","year":"2022","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B84","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/europace\/euaa213","article-title":"Arrhythmic burden in patients with new-onset persistent left bundle branch block after transcatheter aortic valve replacement: 2-year results of the MARE study","volume":"23","author":"Muntan\u00e9-Carol","year":"2020","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B85","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/europace\/euaa149","article-title":"Timing and evolution of advanced conduction disturbances in patients with right bundle branch block undergoing transcatheter aortic valve replacement","volume":"22","author":"Muntan\u00e9-Carol","year":"2020","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B86","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/europace\/euaa241","article-title":"Post-operative cardiac implantable electronic devices in patients undergoing cardiac surgery: a contemporary experience","volume":"23","author":"Waddingham","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B87","first-page":"1335","article-title":"Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery","volume":"19","author":"Wiggins","year":"2017","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B88","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/europace\/eut206","article-title":"2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)","volume":"15","author":"Brignole","year":"2013","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B89","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/2048872619848661","article-title":"Predictors of permanent pacemaker requirement after cardiac surgery for infective endocarditis","volume":"10","author":"Hill","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2023083020435751500_euad202-B90","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/europace\/euw422","article-title":"Single-site ventricular pacing via the coronary sinus in patients with tricuspid valve disease","volume":"20","author":"Noheria","year":"2018","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B91","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/oxfordjournals.eurheartj.a015435","article-title":"Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group","volume":"18","author":"Kappenberger","year":"1997","journal-title":"Eur Heart J"},{"key":"2023083020435751500_euad202-B92","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/europace\/euac104","article-title":"An evaluation of 24h Holter monitoring in patients with myotonic dystrophy type 1","volume":"25","author":"Joosten","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B93","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/europace\/euaa256","article-title":"Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1","volume":"23","author":"Joosten","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B94","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/europace\/euac192","article-title":"Disease progression rate is a strong predictor of ventricular arrhythmias in patients with cardiac laminopathies: a primary prevention cohort study","volume":"25","author":"Rootwelt-Norberg","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B95","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/19491034.2018.1506680","article-title":"Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes","volume":"9","author":"Boriani","year":"2018","journal-title":"Nucleus"},{"key":"2023083020435751500_euad202-B96","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/europace\/euac196","article-title":"Role of genetic testing in young patients with idiopathic atrioventricular conduction disease","volume":"25","author":"Auricchio","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B97","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/europace\/eun021","article-title":"Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices","volume":"10","author":"Roguin","year":"2008","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B98","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/europace\/euz343","article-title":"Magnetic resonance imaging in non-conditional pacemakers and implantable cardioverter-defibrillators: a systematic review and meta-analysis","volume":"22","author":"Munawar","year":"2020","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B99","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/europace\/euac213","article-title":"3 Tesla magnetic resonance imaging in patients with cardiac implantable electronic devices: a single centre experience","volume":"25","author":"Fluschnik","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B100","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/europace\/euz112","article-title":"Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience","volume":"21","author":"Seew\u00f6ster","year":"2019","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B101","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/europace\/euac040","article-title":"EHRA Consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices","volume":"24","author":"Stuhlinger","year":"2022","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B102","first-page":"812","article-title":"Magnetic resonance imaging in patients with cardiac implanted electronic devices: focus on contraindications to magnetic resonance imaging protocols","volume":"19","author":"Horwood","year":"2017","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B103","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/europace\/euv135","article-title":"Radiotherapy in patients with pacemakers and implantable cardioverter defibrillators: a literature review","volume":"18","author":"Zaremba","year":"2016","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B104","doi-asserted-by":"crossref","first-page":"e13862","DOI":"10.1111\/eci.13862","article-title":"A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: prevalence and predictors of device malfunction in 3121 patients","volume":"53","author":"Malavasi","year":"2023","journal-title":"Eur J Clin Invest"},{"key":"2023083020435751500_euad202-B105","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/europace\/euab241","article-title":"Current clinical practice in patients with cardiac implantable electronic devices undergoing radiotherapy: a literature review","volume":"24","author":"Azraai","year":"2021","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B106","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/europace\/eux195","article-title":"Approach to cardio-oncologic patients with special focus on patients with cardiac implantable electronic devices planned for radiotherapy: results of the European Heart Rhythm Association survey","volume":"19","author":"Lenarczyk","year":"2017","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B107","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.hrthm.2023.01.017","article-title":"Right bundle branch pacing: criteria, characteristics, and outcomes","volume":"20","author":"Jastrzebski","year":"2023","journal-title":"Heart Rhythm"},{"key":"2023083020435751500_euad202-B108","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad019","article-title":"Conduction system pacing, a European survey: insights from clinical practice","volume":"25","author":"Keene","year":"2023","journal-title":"Europace"},{"key":"2023083020435751500_euad202-B109","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hrthm.2021.07.057","article-title":"Left bundle branch-optimized cardiac resynchronization therapy (LOT-CRT): results from an international LBBAP collaborative study group","volume":"19","author":"Jastrzebski","year":"2022","journal-title":"Heart Rhythm"},{"key":"2023083020435751500_euad202-B110","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/archsurg.1965.01320170090014","article-title":"Rechargeable pacemaker for direct myocardial implantation","volume":"91","author":"Furman","year":"1965","journal-title":"Arch Surg"},{"key":"2023083020435751500_euad202-B111","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1038\/s41467-021-24417-w","article-title":"Self-rechargeable cardiac pacemaker system with triboelectric nanogenerators","volume":"12","author":"Ryu","year":"2021","journal-title":"Nat Commun"},{"key":"2023083020435751500_euad202-B112","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.hrthm.2022.12.015","article-title":"Remote interrogation and reprogramming of cardiac implantable electronic devices using a custom multivendor solution","volume":"20","author":"Ploux","year":"2023","journal-title":"Heart Rhythm"},{"key":"2023083020435751500_euad202-B113","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/pace.14163","article-title":"Machine learning method for predicting pacemaker implantation following transcatheter aortic valve replacement","volume":"44","author":"Truong","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"key":"2023083020435751500_euad202-B114","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1093\/europace\/euy047","article-title":"Pacemaker-detected severe sleep apnoea predicts new-onset atrial fibrillation","volume":"20","author":"Leggio","year":"2018","journal-title":"Europace"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euad202\/50842019\/euad202.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/8\/euad202\/51308599\/euad202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/8\/euad202\/51308599\/euad202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T20:45:05Z","timestamp":1693428305000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euad202\/7221522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":114,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,25]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euad202","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,7,8]]},"article-number":"euad202"}}